Home About us Current issue Ahead of Print Back issues Submission Instructions Advertise Contact Login   

Search Article 
Advanced search 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 137 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 

ORIGINAL ARTICLE Table of Contents   
Year : 2009  |  Volume : 20  |  Issue : 6  |  Page : 991-994
Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients

1 Dr. Taheri Medical Research Group; Baqiyatallah University of Medical Sciences, Tehran, Iran
2 Dr. Taheri Medical Research Group, Tehran, Iran

Correspondence Address:
Saeed Taheri
Dr. Taheri Medical Research Group, Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah Hospital, Mullasadra Ave, P.O. Box 14155-6437, Postal Code 1435915371, Tehran
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 19861858

Rights and PermissionsRights and Permissions

Cyclosporine is an immunosuppressive agent that displays a broad intra- and inter­individual pharmacokinetic variability. To evaluate the factors, which significantly influence cyclos­porine blood levels in our renal transplant recipients, we studied 611 consecutive patients trans­planted from living donors in Baqiyatallah hospital, Tehran, Iran from 1984 to 2005. The patients were divided into two groups: Group I included patients treated with mycophenolate sodium (MS) as an adjunctive immunosuppressive agent and Group II treated with azathioprine (AZA) as an adjunctive agent. Measurements of cyclosporine blood tough levels (C0) were performed 12 hours after the morning dose (just before the night dose). The mean age of the study population at time of transplantation was 38.7 ± 13.7 years and males formed 67% of it. Univariate analysis and multi­variable linear regression model showed that older age at transplantation, treatment with MS, and time interval from time of transplantation were significantly related with higher C0 levels. We conclude that there is an interaction of immunosuppressive agents in renal transplant patients with higher cyclosporine levels in the recipients of MS.

Print this article  Email this article

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded448    
    Comments [Add]    
    Cited by others 3    

Recommend this journal